| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomea Fusion, Inc. (BMEA) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. BMEA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 723.0K | $1.10M | - | |
| Dir | 241.2K | $367.1K | - | |
| CEO | 115.0K | $175.0K | - | |
| ? | 92.0K | $140.0K | - | |
| Dir | 92.0K | $140.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Erdtmann Rainer M | See Remarks | Buy | 30,000 | $1.43 | $42,999.00 | +4.3% | -1.3% | - | |
| Dec 2, 2025 | Hitchcock Michael J.M.46 | Interim CEO | Buy | 100,000 | $0.99 | $99,180.00 | +666.7% | +42.6% | - | |
| Dec 1, 2025 | Erdtmann Rainer M | See Remarks | Buy | 50,000 | $1.09 | $54,552.00 | +3.8% | +35.1% | - | |
| Sep 30, 2024 | Hitchcock Michael J.M.46 | Director | Buy | 10,000 | $10.06 | $100,600.00 | +200.0% | -61.6% | -80.0% | |
| Jun 11, 2024 | Valle Franco | Chief Financial Officer | Buy | 12,509 | $4.43 | $55,361.08 | +41.7% | +55.3% | -43.6% | |
| Jun 1, 2023 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 125,000 | $34.11 | $4,263,915.00 | -1.7% | -53.6% | -70.5% | |
| May 12, 2023 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 25,000 | $33.84 | $846,000.00 | -0.7% | -45.4% | -68.7% | |
| May 9, 2023 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 250,000 | $34.30 | $8,575,030.00 | -3.2% | -45.8% | -67.2% | |
| Apr 20, 2023 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 200,000 | $29.12 | $5,823,760.00 | -4.9% | -27.0% | -62.9% | |
| Mar 31, 2023 | A2a Pharmaceuticals, Inc.79 | 10% Owner | Sell | 200,000 | $31.25 | $6,250,000.00 | -4.7% | -30.2% | -50.7% |